Jiangsu Hengrui Medicine
600276.SS
#525
Rank
ยฃ36.17 B
Marketcap
ยฃ5.45
Share price
0.29%
Change (1 day)
-18.80%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): ยฃ0.07547

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is ยฃ0.11. In 2022 the company made an earnings per share (EPS) of ยฃ0.06861 a decrease over its 2021 EPS that were of ยฃ0.08276.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ0.0754710%
2022ยฃ0.06861-17.1%
2021ยฃ0.08276-24.44%
2020ยฃ0.1120.3%
2019ยฃ0.0910425.58%
2018ยฃ0.0725027.55%
2017ยฃ0.0568421.64%
2016ยฃ0.0467313.57%
2015ยฃ0.0411439.86%
2014ยฃ0.0294221.33%
2013ยฃ0.0242517.7%
2012ยฃ0.0206025.56%
2011ยฃ0.0164126.22%
2010ยฃ0.0130010.3%
2009ยฃ0.0117857.92%
2008ยฃ0.00746211.06%
2007ยฃ0.00671985.81%
2006ยฃ0.00361687.94%
2005ยฃ0.00192433.97%
2004ยฃ0.00143629.78%
2003ยฃ0.00110719.78%
2002ยฃ0.0009238